Fig. 6
From: A long non-coding RNA signature to improve prognosis prediction of gastric cancer
Kaplan-Meier estimates of the disease free survival (DFS) of GEO patients using the 24-lncRNA signature, stratified by TNM stage (I, II, III & IV). Kaplan-Meier plots were then used to visualize the survival probabilities for the high-risk versus low-risk group of patients determined on the basis of the median risk score from the entire GSE62254 set patients within each TNM stage. a Kaplan-Meier curves for patients with TNM stage I (N = 30); (b) Kaplan-Meier curves for patients with TNM stage II (N = 97); (c) Kaplan-Meier curves for patients with TNM stage III (N = 96); (d) Kaplan-Meier curves for patients with TNM stage IV (N = 77). The tick marks on the Kaplan-Meier curves represent the censored subjects. The differences between the two curves were determined by the two-sided log-rank test